Where does National Center OF Neurology AND Psychiatry rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), National Center OF Neurology AND Psychiatry ranks #8,448 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does National Center OF Neurology AND Psychiatry hold?

National Center OF Neurology AND Psychiatry holds 38 US utility patents granted between 2015 and 2024, spanning 12 technology areas.

What is National Center OF Neurology AND Psychiatry's Innovation Score?

National Center OF Neurology AND Psychiatry has an Innovation Score of 33.5 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is National Center OF Neurology AND Psychiatry's patent grant rate increasing or decreasing?

National Center OF Neurology AND Psychiatry's recent grant velocity is +71% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for National Center OF Neurology AND Psychiatry's patents?

National Center OF Neurology AND Psychiatry's patents average 9.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Center OF Neurology AND Psychiatry

Q: What technology areas does National Center OF Neurology AND Psychiatry focus on?

National Center OF Neurology AND Psychiatry's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 31 patents, ranking #634 of 6,058 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Q: How is the National Center OF Neurology AND Psychiatry patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 38 granted patents across 12 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, National ranks #8,448 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 12 technology areas.

#8,448
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.5/100): 9.9
avg claims per patent: +71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8448 · Foreign Corporation #8,448 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,448/49,997
PHOTO-FINISH Minimax & KG
CPC-FOCUS A61P · 12 areas
INNOV-THIN 33.5/100
CLAIMS-PAR 9.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Minimax GmbH & Co KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 33.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (38%) Velocity 2.7 pts (8%) Breadth 12.2 pts (36%) Claim depth 5.9 pts (18%)

Qualcomm Incorporated · highest

85
National Center OF… · this assignee

34
OPW-Engineered Systems · near

34
Larson Manufacturing… · near

34
Pavillon Data Systems · near

34
World Emergency… · near

34
3D Lighting… · lowest

7

What this shows National's Innovation Score is 33.5/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 9.9 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Center OF Neurology AND Psychiatry is a focused PatentsView assignee: 12 CPC subclasses with 81.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (8 grants) versus a trough of 1 in 2016. By volume, National sits between Minimax GmbH & Co KG and National Steel Car Limited.

National's three-year grant acceleration

From 2019–2021 to 2022–2024, National Center OF Neurology AND Psychiatry moved from 20 to 8 grants (0.40x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Minimax & KG

38
Morpho Detection

38
Musculoskeletal T…

38
Nalux

38
Nidec Copal

38
Nippon Chemiphar

38
National Chain

38
National Steel Car

38
National Center O… ◀

38

What this shows National holds 38 patents at rank #8,448, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near National

By rank, the assignees closest to #8,448 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for National, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), National ranks #634 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

OPW-Engineered Systems, Inc. 34 Larson Manufacturing Company of South Dakota, LLC 34 World Emergency Network-Nevada, Ltd. 34 Pavillon Data Systems, Inc. 34

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

National Center OF Neurology AND Psychiatry patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.3%
2016	1	2.6%
2017	4	10.5%
2018	3	7.9%
2019	4	10.5%
2020	8	21.1%
2021	8	21.1%
2023	5	13.2%
2024	3	7.9%

Which technologies does National Center OF Neurology AND Psychiatry patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 31

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 31

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 19

C07K - Peptides 18

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 14

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61B - DIAGNOSIS; SURGERY; Identification 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 1

G06V - Image OR Video Recognition OR Understanding 1

G06F - Electric Digital Data Processing 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

National Center OF Neurology AND Psychiatry's patent record in context - here's where to go next.

National Center OF Neurology AND Psychiatry's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 81.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,448 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare National Center OF Neurology AND Psychiatry against Minimax GmbH & Co KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.